Biologics APIs

Jul 09, 2018
By Pharmaceutical Technology Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
Jul 02, 2018
Pharmaceutical Technology
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
Jul 02, 2018
Pharmaceutical Technology
After 30 years of biologic-drug advances, the industry and patients still have a lot to learn.
Jun 22, 2018
By Pharmaceutical Technology Editors
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
Jun 22, 2018
By Pharmaceutical Technology Editors
The company has completed the first phase of expansion at its headquarters in Freiburg, Germany, in anticipation of increasing demand as cell and gene therapies approach commercialization.
Jun 21, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
Jun 07, 2018
By Pharmaceutical Technology Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
Jun 04, 2018
By Pharmaceutical Technology Editors
EMA has recommended marketing authorization for Aimovig (erenumab), a new treatment for migraine.
Jun 04, 2018
By Pharmaceutical Technology Editors
The agency has recommended approval of three biosimilar adalimumab products from Novartis, referencing AbbVie’s Humira, and a biosimilar trastuzumab from Pfizer, referencing Roche’s Herceptin.
Jun 01, 2018
By Pharmaceutical Technology Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
native1_300x100
lorem ipsum